Jacqueline E. Shea - 26 Feb 2023 Form 4 Insider Report for INOVIO PHARMACEUTICALS, INC. (INO)

Role
Chief Executive Officer, Director
Signature
/s/ Jacqueline E. Shea
Issuer symbol
INO
Transactions as of
26 Feb 2023
Net transactions value
-$54,109
Form type
4
Filing time
28 Feb 2023, 16:44:25 UTC
Previous filing
11 May 2022
Next filing
13 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INO Common Stock Options Exercise +22,544 +29% 99,099 26 Feb 2023 Direct F1
transaction INO Common Stock Tax liability $12,529 -9,788 -9.9% $1.28 89,311 26 Feb 2023 Direct F2
transaction INO Common Stock Options Exercise +70,234 +79% 159,545 26 Feb 2023 Direct F3
transaction INO Common Stock Tax liability $41,581 -32,485 -20% $1.28 127,060 26 Feb 2023 Direct F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INO Restricted Stock Unit Options Exercise $0 -22,544 -50% $0.000000 22,544 26 Feb 2023 Common Stock 22,544 Direct F1
transaction INO Restricted Stock Unit Options Exercise $0 -70,234 -33% $0.000000 140,466 26 Feb 2023 Common Stock 70,234 Direct F3
transaction INO Common Stock Option Award $0 +836,800 $0.000000 836,800 27 Feb 2023 Common Stock 836,800 $1.24 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of common stock. On February 26, 2021, the reporting person was granted 67,633 restricted stock units, vesting as follows: 22,545 shares vested on February 26, 2022; 22,544 shares vested on February 26, 2023; and 22,544 shares will vest on February 26, 2024. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.
F2 The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in footnote (1) herein.
F3 Each restricted stock unit represents a contingent right to receive one share of common stock. On February 26, 2022, the reporting person was granted 210,700 restricted stock units, vesting as follows: 70,234 shares vested on February 26, 2023; 70,233 shares will vest on February 26, 2024; and 70,233 shares will vest on February 26, 2025. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.
F4 The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in footnote (3) herein.
F5 The vesting schedule for the 836,800 options is as follows: 209,200 shares vested on February 27, 2023; 209,200 shares will vest on February 26, 2024; 209,200 shares will vest on February 26, 2025; and 209,200 shares will vest on February 26, 2026.